
doi: 10.1007/bf00286707
pmid: 2476375
Human lymphocyte cultures were treated with 5-azadeoxycytidine for the induction of the common fragile sites at 1q42 and 19q13 and with 5-bromodeoxyuridine for differential sister chromatid staining. A remarkably high frequency of sister chromatid exchanges was observed directly at the gaps of both fragile sites. In addition, the rate of sister chromatid exchanges occurring at the region corresponding to 1q42 without a concurrent visible gap was also increased. This confirms previous data on increased intrachromosomal recombination in common and rare fragile sites of various categories.
Chromosome Fragile Sites, Chromosome Fragility, Decitabine, Chromosome Banding, Bromodeoxyuridine, Chromosomes, Human, Pair 1, Karyotyping, Azacitidine, Humans, Chromosomes, Human, Pair 19, Sister Chromatid Exchange, Cells, Cultured
Chromosome Fragile Sites, Chromosome Fragility, Decitabine, Chromosome Banding, Bromodeoxyuridine, Chromosomes, Human, Pair 1, Karyotyping, Azacitidine, Humans, Chromosomes, Human, Pair 19, Sister Chromatid Exchange, Cells, Cultured
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 25 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
